01. COVID-19
SimulationsPlus can help you respond to COVID-19
Solving the global COVID-19 pandemic will require innovative and integrative new approaches to accelerate drug development.

From lead discovery to re-purposing of promising existing therapies, to predicting whole-body and target tissue drug exposure, to understanding interactions between treatment and disease in both the acute and chronic setting, to de-risking clinical trials and maximizing patient benefit, Simulations Plus has the tools and expertise to move your COVID-19 drug development program forward. Watch this video to learn what our divisional Presidents have committed to fighting the COVID-19 pandemic.

Meet the Experts

Hover over the elements for more information.